What is the current Price Target for the Corbus Pharmaceuticals Holdings Inc stock?

The average Corbus Pharmaceuticals Holdings Inc target price is $52.11. This is 959.17% higher than the current stock price. The highest price target is 1,383.74%, the lowest is 611.38%. 9 Analysts have issued a price target Corbus Pharmaceuticals Holdings Inc 2026 .

How high will the Corbus Pharmaceuticals Holdings Inc stock rise?

No reliable answer can be given as to how high the Corbus Pharmaceuticals Holdings Inc stock will rise. The performance of stocks, including the Corbus Pharmaceuticals Holdings Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Corbus Pharmaceuticals Holdings Inc stock today?

The performance of Corbus Pharmaceuticals Holdings Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Corbus Pharmaceuticals Holdings Inc stock fall?

The decline in Corbus Pharmaceuticals Holdings Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Corbus Pharmaceuticals Holdings Inc Forecast, price target & analysts

$4.90

0.41% today

Nasdaq, Apr 04, 08:15 pm CET

ISIN

US21833P1030

Symbol

CRBP

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Corbus Pharmaceuticals Holdings Inc Target price 2025 - Analyst rating & recommendation

Corbus Pharmaceuticals Holdings Inc Classifications & Recommendation:

Buy

100%

Corbus Pharmaceuticals Holdings Inc Price Target

Target Price	$52.11
Price	$4.92
Potential	959.17% register free of charge
Number of Estimates	9

	9 Analysts have issued a price target Corbus Pharmaceuticals Holdings Inc 2026 . The average Corbus Pharmaceuticals Holdings Inc target price is $52.11. This is 959.17% register free of charge higher than the current stock price. The highest price target is $73.00 1,383.74% register free of charge , the lowest is $35.00 611.38% register free of charge .
	A rating was issued by 10 analysts: 10 Analysts recommend Corbus Pharmaceuticals Holdings Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Corbus Pharmaceuticals Holdings Inc stock has an average upside potential 2026 of 959.17% register free of charge . Most analysts recommend the Corbus Pharmaceuticals Holdings Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.68	-4.25
	64.31%	15.49%
P/E		negative
EV/Sales		negative

2 Analysts have issued a Corbus Pharmaceuticals Holdings Inc forecast for earnings per share. The average Corbus Pharmaceuticals Holdings Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.68	64.31%
2025	$-4.25 15.49% Unlock
2026	$-5.53 30.12% Unlock
2027	$-8.10 46.47% Unlock
2028	$-7.16 11.60% Unlock
2029	$-5.90 17.60% Unlock

Current	-1.34	64.55%
2025	-1.16 13.43% Unlock
2026	-0.89 23.28% Unlock
2027	-0.61 31.46% Unlock
2028	-0.69 13.11% Unlock
2029	-0.83 20.29% Unlock

Corbus Pharmaceuticals Holdings Inc...

Current Corbus Pharmaceuticals Holdings Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 12 2025
Jefferies	Locked ➜ Locked	Locked	Mar 11 2025
William Blair	Locked ➜ Locked	Locked	Feb 28 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 18 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 10 2025
Piper Sandler	Locked ➜ Locked	Locked	Dec 02 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 23 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 12 2025
Locked Jefferies: Locked ➜ Locked	Mar 11 2025
Locked William Blair: Locked ➜ Locked	Feb 28 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 18 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 10 2025
Locked Piper Sandler: Locked ➜ Locked	Dec 02 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 23 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now